Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

  • This share is currently suspended. It was suspended at a price of 0.306
  • There is currently no data for BMN

Agreement on Convertible Loan Note Refinancing

27 Nov 2023 07:00

RNS Number : 6740U
Bushveld Minerals Limited
27 November 2023
 

Market Abuse Regulation ("MAR") Disclosure

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

Bushveld Minerals Limited

("Bushveld" or the "Company")

 

Agreement on Convertible Loan Note Refinancing

 

27 November 2023

 

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that it has entered into a conditional agreement to refinance its existing convertible loan notes with Orion Mine Finance ("Orion"), following the Term Sheet agreed in May this year.

 

Highlights:

 

§ Today's conditional agreement extends the maturity date for Bushveld's existing convertible loan notes to 31 January 2024 (from 21 December 2023) and refinances the convertible debt obligations of c.US$46.9 million (including accrued interest) as follows:

· Conversion of 10% of the outstanding balance (including interest) of the convertible debt obligations ("CLN Balance"), expected to be c.US$4.7 million, as at the effective date[1] into shares at 3.00p per share.

· A new convertible loan note of c.US$14.1 million representing 30% of the CLN Balance maturing in June 2028.

· A term loan of c.US$28.1 million representing 60% of the CLN Balance.

· Supplemental royalty at not more than 0.264% of Bushveld's gross revenues and reducing by 80% at the term loan maturity.

 

§ New structure better aligns repayment with expected internal cash generation projections.

 

§ The refinancing is conditional upon (inter alia):

· Entry into the finance and security documents, which are progressing accordingly.

· Bushveld shareholder approval.

· Raising of at least US$12.0 million via the issue of new ordinary shares in the Company to third party and existing investors (which would be satisfied by the proposed equity investment by Southern Point Resources - Fund 1 SA L.P., represented by its general partner SPR GP1 Proprietary Limited).

· Consent by the Financial Surveillance Department of the South African Reserve Bank.

· Completion of the Share Exchange transaction between the Company and the minority shareholders in Bushveld Vametco Holdings Pty Ltd, by which the Company will become the 100% shareholder in Bushveld Vametco Holdings Pty Ltd, as announced on 30 October 2023.

 

§ All outstanding conditions are expected to be satisfied in due course, and the transaction is expected to complete before the 31 January 2024 deadline agreed by all parties.

 

 

 

Craig Coltman, CEO of Bushveld Minerals commented:

"I am pleased to announce today's agreement with Orion, which has supported the Company since it's initial investment three years ago. Since first announcing the terms of the proposed restructuring earlier this year, there has been an imperative to enter into a binding agreement with Orion, and whilst the refinancing remains conditional upon certain items, including Bushveld shareholders' approval, it provides certainty as we move forward with the other elements of our financial package.

The restructuring is a key part of our strategy to restore value in the Company, along with ensuring Bushveld delivers its operational targets, simplifies its corporate structure and refines its investment proposition."

 

 

Key Terms of the Proposed Refinancing

§ 10% of the CLN Balance (c. US$4.7 million) to be capitalised into a subscription for shares in Bushveld at 3.00p per share, a 48% premium to the 20-day weighted average share price (as at 24 November 2023).

 

§ 30% of the CLN Balance (c.US$14.1 million) to remain as a convertible loan note with the following revised terms ("New CLN"):

· Interest: 12%

· Conversion price: 3.99p

· Maturity Date: 30 June 2028

· Bushveld shall have a one-time right to redeem 50% (in whole and not in part) of the New CLN in June 2026, subject to the right of Orion to elect for conversion of the same for a 30-day period.

 

§ 60% of the CLN Balance (c.US$28.1 million) will be converted into a secured term loan ("Term Loan") on the following terms:

· Interest: 6.0% ("Margin") plus the greater of (i) 3-month Secured Overnight Financing Rate ("SOFR") and (ii) 3.0% per annum.

· Interest payable quarterly in arrears in cash starting from the last business day of the quarter in which the closing of the transaction occurs and on the last business day of each quarter thereafter. In the event that the Company has insufficient cash available to pay interest on its due date, the interest due on that date shall continue to accrue. In the event of default, the Margin will be increased by 3%.

 Principal repayments structured to

a. 25% of the facility amount (c. US$7.0 million) to be repaid by 30 June 2024

b. 30% of the facility amount (c. US$8.4 million) to be repaid by 30 June 2025

c. 45% of the facility amount (c. US$12.6 million) to be repaid by 30 June 2026

 

· The facility may be prepaid in whole or in part at any time. Prepayment is subject to the following early redemption fee schedule based on the outstanding balance at the time of prepayment.

Prior to 30 June 2024: 4%

After 30 June 2024 until 30 June 2025: 3%

After 30 June 2025 until 30 June 2026: 2% 

 

§ Supplemental royalty, on the same terms as the existing Production Financing Agreement during the tenure of the Term Loan, except for the following:

· Royalty repayment rate of 0.264% with a realised price per kgV of less than US$47/kgV.

· Royalty repayment rate of 0.216% with a realised price per kgV of greater than US$47/kgV.

· The later of 30 June 2027 and when the Term Loan has been fully repaid, the repayment rate will reduce by 80% and shall be payable for the life of the Vametco operation.

 

 

 

ENDS

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

 

 

 


[1] The date on which all conditions referred to below are satisfied.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDBBDBDDDDGXL
Date   Source Headline
16th May 20257:00 amRNSCancellation - Bushveld Minerals Limited
15th Apr 20254:28 pmRNSAppointment of Liquidators & Resignation of Nomad
11th Apr 20257:57 amRNSNotice of appointment of liquidators
15th Jan 20256:00 pmRNSBushveld Minerals
16th Dec 20247:15 amRNSBusiness Rescue and Operations Update
4th Dec 20247:00 amRNSResignation of Directors
29th Nov 20247:00 amRNSDefault on Shareholder Loan Repayment by Vanchem
19th Nov 202410:01 amRNSAppointment of Business Rescue Practitioners
18th Nov 20247:30 amRNSSuspension - Bushveld Minerals Limited
18th Nov 20247:00 amRNSTrading Suspension
8th Nov 20249:25 amRNSQ3 and 9M 2024 Operational Update
1st Nov 20243:05 pmRNSVanchem Sale Update
25th Oct 20242:21 pmRNSOperational Update
18th Oct 20249:18 amRNSDisposal of Interests in Lemur Holdings Limited
17th Sep 20247:00 amRNSInterim Results for Six Months ended 30 June 2024
10th Sep 20247:00 amRNSTurnaround Initiatives Underway
2nd Sep 20244:22 pmRNSOrion Matched Funding Received
14th Aug 20246:00 pmRNSSARB Approval for Orion US$10M Matched Funding
12th Aug 20244:13 pmRNSUS$2 million SPR Debt Funding Received
9th Aug 20249:55 amRNSAgreement re Settlement of SPR Subscription Funds
7th Aug 20244:25 pmRNSAnnual General Meeting Results
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSAnnual General Meeting Statement
31st Jul 20247:00 amRNSQ2 and H1 2024 Operational Update
24th Jul 20244:46 pmRNSHolding(s) in Company - Correction
15th Jul 202412:39 pmRNSDirector/PDMR Shareholding
12th Jul 20244:57 pmRNSDirector/PDMR Shareholding
11th Jul 20245:04 pmRNSPosting of Accounts & Notice of General Meeting
28th Jun 20245:30 pmRNSFinal Results for Year Ended 31 December 2023
28th Jun 20243:29 pmRNSFinancing Update: Orion matched funding of US$10m
28th Jun 20241:17 pmRNSHolding(s) in Company
26th Jun 202412:13 pmRNSHolding(s) in Company
24th Jun 20241:50 pmRNSSPR Funding & Orion 2024 Financing Package Update
31st May 20244:07 pmRNSCCSA Approval for sale of 64% interest in Mokopane
31st May 20241:07 pmRNSResult of Meeting
24th May 20245:53 pmRNSShareholder Correspondence and Questions & Answers
13th May 20247:00 amRNSPosting of Circular and Notice of General Meeting
7th May 20247:00 amRNSProposed conditional disposal of Vanchem
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.